These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2895596)

  • 1. Myocardial ischemia in untreated hypertensive patients: effect of a single small oral dose of a beta-adrenergic blocking agent.
    Stone JG; Foëx P; Sear JW; Johnson LL; Khambatta HJ; Triner L
    Anesthesiology; 1988 Apr; 68(4):495-500. PubMed ID: 2895596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxprenolol in myocardial infarction survivors: brief review of the European Infarction Study results in the light of other beta-blocker post infarction trials.
    Schröder R
    Z Kardiol; 1985; 74 Suppl 6():165-72. PubMed ID: 2869616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of labetalol, the first alpha- and beta-blocking agent.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):617-28. PubMed ID: 2867049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative sympatholysis. Beneficial effects of the alpha 2-adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. McSPI--Europe Research Group.
    Anesthesiology; 1997 Feb; 86(2):346-63. PubMed ID: 9054253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labetalol in the treatment of angina pectoris.
    Kanto JH
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):166-74. PubMed ID: 2881899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blocking therapy in patients with the Marfan syndrome and entire aortic replacement.
    Meijboom LJ; Westerhof BE; Nollen GJ; Spaan JA; de Mol BA; Jacobs MJ; Mulder BJ
    Eur J Cardiothorac Surg; 2004 Nov; 26(5):901-6. PubMed ID: 15519180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Do beta-blockers prevent coronary events in hypertensive patients?].
    Diévart F; Ragot S; Julien J; Herpin D
    Arch Mal Coeur Vaiss; 2005 Sep; 98(9):881-8. PubMed ID: 16231574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance contrast enhancement with gadolinium-DTPA in patients with angina and angiographically normal coronary arteries: effect of chronic beta-blockade.
    Rossetti E; Fragasso G; Mellone R; Vanzulli A; Del Maschio A; Chierchia SL
    Cardiologia; 1999 Jul; 44(7):653-9. PubMed ID: 10476591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory effects of four adrenergic blocking agents combined with a diuretic in treating hypertension with concurrent chronic obstructive lung disease.
    Dal Negro RW; Zoccatelli O; Pomari C; Trevisan F; Turco P
    Int J Clin Pharmacol Res; 1986; 6(4):283-9. PubMed ID: 2875954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Physiopathologic introduction to anesthesia and resuscitation of the vascular patient].
    Coriat P
    J Mal Vasc; 1998 Feb; 23(1):35-40. PubMed ID: 9551351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation by exercise test of effects of a single oral dose of atenolol in patients with stable angina (author's transl)].
    de Divitiis O; de Simone G; Maddalena G; Castaldo M; Ruggiano A
    G Ital Cardiol; 1981; 11(12):2088-96. PubMed ID: 7049818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sildenafil citrate upon myocardial ischemia in patients with chronic stable angina in therapy with beta-blockers.
    Patrizi R; Leonardo F; Pelliccia F; Chierchia SL; Galetta P; Cerquetani E; Frascà F; Fini M; Rosano GM
    Ital Heart J; 2001 Nov; 2(11):841-4. PubMed ID: 11770869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Lehto M; Gerdts E; Olsen MH; Hornestam B; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):712-9. PubMed ID: 15734615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of fentanyl and nitroglycerin in prevention of myocardial ischemia associated with laryngoscopy and tracheal intubation in patients undergoing operations of short duration.
    Fusciardi J; Godet G; Bernard JM; Bertrand M; Kieffer E; Viars P
    Anesth Analg; 1986 Jun; 65(6):617-24. PubMed ID: 3085552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of beta-adrenoceptor blockade during anesthesia in humans: use of isoproterenol dose-response curves.
    Dagnino J; Prys-Roberts C
    Anesth Analg; 1985 Mar; 64(3):305-11. PubMed ID: 2858167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary prevention with beta-blockade in patients with hypertension: review of results and clinical implications.
    Wikstrand J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S64-75. PubMed ID: 11527139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.